How Much Did Bio-Therapeutic Raise?
Funding & Key Investors

Bio-Therapeutic has successfully secured a significant capital injection, marking a pivotal moment in its corporate trajectory. With a total cumulative backing of $350K, the firm continues to solidify its presence in the high-growth aesthetics market. This latest infusion of $350K represents a major strategic investment, underscoring investor confidence in the company's long-term scalability and its robust portfolio of professional-grade dermatological solutions.

What is Bio-Therapeutic?

Bio-Therapeutic
ManufacturingCosmetics, Beauty Supply & Personal Care ProductsMedical Devices & Equipment

Bio-Therapeutic operates at the intersection of advanced engineering and clinical skincare, specializing in the development of sophisticated equipment designed for both professional spa environments and the consumer market. The company's core product architecture includes high-precision microcurrent facial toning systems, advanced microdermabrasion platforms, and specialized microexfoliation tools. By bridging the gap between clinical-grade efficacy and accessible home-care technology, Bio-Therapeutic has established a dominant market position. Their comprehensive ecosystem, which integrates hardware with proprietary serums and masques, addresses the increasing demand for non-invasive, technology-driven skin health interventions. This dual-channel approach allows the firm to capture value across both the B2B professional services sector and the direct-to-consumer beauty tech landscape.

How much funding has Bio-Therapeutic raised?

Bio-Therapeutic has raised a total of $350K across 1 funding round:

2020

Debt

$350K

Debt (2020): $350K with participation from PPP

Key Investors in Bio-Therapeutic

PPP

Public-Private Partnership

What's next for Bio-Therapeutic?

With this late-stage financing secured, Bio-Therapeutic is well-positioned to accelerate its global market penetration and R&D initiatives. The strategic allocation of this capital will likely focus on expanding the company's digital footprint and enhancing its microsonic and ultrasonic product lines to meet evolving consumer preferences for personalized skincare. As the firm transitions into this next phase of growth, the focus will remain on maintaining its technological edge in the competitive aesthetics industry. By leveraging its established reputation among spa professionals, Bio-Therapeutic is poised to scale its operations, potentially exploring new international markets and further diversifying its product offerings to include more integrated, data-driven skincare solutions that align with modern wellness trends.

See full Bio-Therapeutic company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Food & BeverageManufacturing
ManufacturingTelecommunication Equipment
Cosmetics, Beauty Supply & Personal Care ProductsManufacturingRetailFlowers, Gifts & Specialty Stores
Cosmetics, Beauty Supply & Personal Care ProductsManufacturingSpa and Salon ManagementConsumer Services

Frequently Asked Questions Regarding Bio-Therapeutic Financial Insights

What are the most recent funding rounds that Bio-Therapeutic has completed, and what were the funding rounds?
Bio-Therapeutic has recently completed 1 funding rounds: Debt on Apr 7, 2020.
What is the total amount of funding Bio-Therapeutic has raised to date?
Bio-Therapeutic has raised a total of $350K in funding to date.
How many funding rounds has Bio-Therapeutic completed?
Bio-Therapeutic has completed 1 funding rounds.
How much funding did Bio-Therapeutic raise in its most recent funding round?
Bio-Therapeutic raised $350K in its most recent funding round.
Who are the lead investors in Bio-Therapeutic's latest funding round?
The lead investor in Bio-Therapeutic's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Bio-Therapeutic's history?
The largest funding round in Bio-Therapeutic's history was $350K.
See more information about Bio-Therapeutic